NORFLEX orphenadrine citrate 100 mg slow release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

norflex orphenadrine citrate 100 mg slow release tablet blister pack

inova pharmaceuticals (australia) pty ltd - orphenadrine citrate, quantity: 100 mg - tablet, modified release - excipient ingredients: ethylcellulose; lactose monohydrate; magnesium stearate; colloidal anhydrous silica - relief of painful muscle spasm associated with fibrositis, whiplash injuries, torticollis, prolapsed intervertebral disc, strains, sprains and similar conditions. has also been shown to be of value in tension headache and persistent hiccup.

Norflex-Co Tablet Kenya - English - Pharmacy and Poisons Board

norflex-co tablet

orphenadrine citrate paracetamol - tablet - orphenadrine citrate 35 mg/tablet paracetamol 450… - orphenadrine combinations

Norflex New Zealand - English - Medsafe (Medicines Safety Authority)

norflex

inova pharmaceuticals (new zealand) limited - orphenadrine citrate 100mg - tablet - 100 mg - active: orphenadrine citrate 100mg excipient: colloidal silicon dioxide ethylcellulose lactose monohydrate magnesium stearate - norflex (orphenadrine citrate) is indicated for the relief of stiffness and pain resulting from skeletal muscle spasm in sprains and strains, local muscle injury, prolapsed intervertebral disc, lumbago, fibrositis, non-articular rheumatism, acute torticollis, surgery, fractures, anxiety and tension. orphenadrine citrate has also been shown to be effective for treatment of tension headache and persistent hiccoughs.

Orfenal 50mg coated Tablets Malta - English - Medicines Authority

orfenal 50mg coated tablets

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - orphenadrine hydrochloride - coated tablet - orphenadrine hydrochloride 50 mg - anti-parkinson drugs

NORFLEX orphenadrine citrate 100 mg slow release tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

norflex orphenadrine citrate 100 mg slow release tablet bottle

inova pharmaceuticals (australia) pty ltd - orphenadrine citrate, quantity: 100 mg - tablet, modified release - excipient ingredients: ethylcellulose; lactose monohydrate; magnesium stearate; colloidal anhydrous silica - relief of painful muscle spasm associated with fibrositis, whiplash injuries, torticollis, prolapsed intervertebral disc, strains, sprains and similar conditions. has also been shown to be of value in tension headache and persistent hiccup.

ORPHENADRINE Oral Solution 50 MG/5ml Ireland - English - HPRA (Health Products Regulatory Authority)

orphenadrine oral solution 50 mg/5ml

rosemont pharmaceuticals ltd - orphenadrine - oral solution - 50 mg/5ml

Norgesic blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

norgesic blister pack

inova pharmaceuticals (australia) pty ltd - orphenadrine citrate, quantity: 35 mg; paracetamol, quantity: 450 mg - tablet, uncoated - excipient ingredients: pregelatinised maize starch; colloidal anhydrous silica; microcrystalline cellulose; magnesium stearate; gelatin - tension headache, occipital headaches associated with spasm of skeletal muscles in the region of the head and neck. acute and traumatic conditions of the limbs and trunk: sprains, strains, whiplash injuries, acute torticollis, prolapsed intervertebral disc.

Disipal New Zealand - English - Medsafe (Medicines Safety Authority)

disipal

seqirus (nz) ltd - orphenadrine hydrochloride 50mg; orphenadrine hydrochloride 50mg; orphenadrine hydrochloride 50mg - coated tablet - 50 mg - active: orphenadrine hydrochloride 50mg excipient: acacia gelatin lactose monohydrate polyvinyl acetate potato starch purified talc   shellac stearic acid sucrose   titanium dioxide white beeswax active: orphenadrine hydrochloride 50mg excipient: acacia   calcium carbonate calcium phosphate gelatin opaseal p-17-0200 opalux as 3026 yellow - contains tartrazine kaolin lactose monohydrate magnesium stearate maize starch opacode black s-1-27794 opaglos white 6000 purified talc stearic acid sucrose   titanium dioxide active: orphenadrine hydrochloride 50mg excipient: acacia   calcium carbonate calcium phosphate gelatin opaseal p-17-0200 opalux as 3026 yellow - contains tartrazine kaolin lactose monohydrate magnesium stearate maize starch opaglos white 6000 purified talc stearic acid sucrose   titanium dioxide - parkinson's disease, all forms of parkinsonism.